ClinicalTrials.Veeva

Menu

Empirical Antibiotic and Outcome in Community-onset Bacteremia

P

Phramongkutklao College of Medicine and Hospital

Status

Completed

Conditions

Bacteremia

Study type

Observational

Funder types

Other

Identifiers

NCT03765749
PMK-032

Details and patient eligibility

About

Empirical antibiotic and outcome in Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae

Full description

Prospective cohort study is conducted for monitoring outcomes and risk factors among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae.

Primary endpoint is mortality rate among those who received initially inappropriate antimicrobial which switch to appropriate antimicrobial later when culture and antimicrobial susceptibility test reported among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae.

Enrollment

108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae. Age > 18 years

Exclusion criteria

  • Pregnancy
  • Polymicrobial infection

Trial design

108 participants in 2 patient groups

Community onset 3rd generation cephalosporin resistant entero
Description:
Patient with Community onset third generation cephalosporin resistant enterobacteriaceae bacteremia who received inappropriate Antibiotic
Nosocomial onset 3rd generation cephalosporin resistant ente
Description:
Patient with Nosocomial onset third generation cephalosporin resistant enterobacteriaceae bacteremia who received appropriate Antibiotic

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems